CyberKnife Market Size Worth $1,787.9 Million By 2030

CyberKnife Market Growth & Trends

The global cyberKnife market size is expected to reach USD 1,787.9 million by 2030, registering a CAGR of 18.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Introduction of new technologically advanced products that reduces the overall time it takes to conduct the procedure is driving the market growth.

Major market players are focusing on launching their technologically advanced products in established as well as emerging markets. In addition, they are also aiming to spread their presence in under-developed regions which can serve as a major life saving factor in these regions. For instance, in September 2022, Accuray Incorporated announced the launch of its new CyberKnife system in Africa with an aim to provide access to extremely precise stereotactic radiosurgery and stereotactic body radiation therapy to more patients.  

Moreover, partnerships and collaborations by the key manufacturers in the market are also driving the sales of the cyberKnife market. For instance, in October 2022, Accuray collaborated with Brain lab to enhance and expand the capabilities of its cyberKnife platform for the neuro-radiosurgery market. The collaboration will offer Accuray, Incorporated, access to Brain lab elements planning software to the neuro-radiosurgery community.

Another factor leading to a rise in sales of cyberKnife is the favorable reimbursement scenario across different applications. In October 2022, Japanese Ministry of Health, Labor, and Welfare approved reimbursement for the cyberKnife system for the treatment of trigeminal neuralgia. Since its introduction, the cyberKnife system has evolved as a full-body radiosurgery system that enables consistent delivery of extremely precise treatments to tumors throughout the body. Thus, representing lucrative growth opportunities during the forecast period.

 Request a free sample copy or view report summary: CyberKnife Market Report

CyberKnife Market Report Highlights

• Cancer dominated the market with the largest revenue share in 2022 owing to increasing prevalence and rising adoption of the cyberKnife for this application

• The vascular malformation segment is predicted to undergo maximum growth owing to new product launches for this application     

• The hospitals segment accounted for the highest market share in 2022 owing to the large number of radiation therapy procedures being carried out in this facility

• Outpatient facilities are expected to render the highest growth during  the forecast period due to the increasing number of patients opting for these facilities because of the advantages such as lower cost and shorter hospital stay      

• North America dominated the market due to the high penetration rate of technologically advanced products and large patient pool

• The growing burden of cancer, rise in disposable income in Asia Pacific countries and growing geriatric population is driving the market growth in the region

CyberKnife Market Segmentation

Grand View Research has segmented the global cyberKnife market based on the application, end-use, and region:

CyberKnife Application Outlook (Revenue, USD Million, 2018 - 2030)

• Tumor

• Cancer

• Vascular Malformation

• Others

CyberKnife End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient Facilities

• Research and Manufacturing

CyberKnife Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Thailand

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait 

List of Key Players in the CyberKnife Market

• Accuray Incorporated

• Varian Medical Systems

• Koninklijke Philips